The US government agency will hold roundtables with patient groups for each of the 15 impacted medicines and a town hall with clinicians before making any decision on the price reductions.
All manufacturers decide to participate in the second cycle of US price negotiation
March 19, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Imugene's azer-cel granted FDA Fast Track Designation in blood cancer
March 19, 2025 - - Australian Biotech -
Island raises $2.72 million through exercise of listed options
March 19, 2025 - - Australian Biotech -
All manufacturers decide to participate in the second cycle of US price negotiation
March 19, 2025 - - Latest News -
Recognition for outstanding results in Medicines Australia’s Continuing Education Program
March 19, 2025 - - Latest News -
Caretaker convention creates PBS uncertainty, at the very least
March 19, 2025 - - Latest News -
Governor-General supports earlier diagnosis and greater awareness of juvenile arthritis
March 18, 2025 - - Latest News -
UK industry in shock over significant increase in payment rate
March 18, 2025 - - Latest News